Cardlytics (CDLX) Tops Q1 EPS by 13c

Cardlytics (NASDAQ: CDLX) reported Q1 EPS of ($0.23), $0.13 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $36 million versus the consensus estimate of $36.11 million.

For earnings history and earnings-related data on Cardlytics (CDLX) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Morgan Stanley Starts Target Hospitality (TH) at Overweight
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c